🔎 Trials Near Me

Akèy › Kansè Endomèt › Minnesota › Saint Paul

Etid klinik pou Kansè Endomèt nan Saint Paul, MN

6 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Saint Paul (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Ap rekriteFaz 2
  • Regions Hospital, Saint Paul
  • United Hospital, Saint Paul
  • Saint John's Hospital - Healtheast, Maplewood · 5 mi lwen
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT05564377

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Ap rekriteFaz 3
  • Regions Hospital, Saint Paul
  • United Hospital, Saint Paul
  • Minnesota Oncology Hematology PA-Woodbury, Woodbury · 7 mi lwen
Laj 18 ak plis · Fanm · Mizajou Oct 2, 2026 · NCT07198074

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 2
  • Health Partners Cancer Center at Regions Hospital, Saint Paul
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Ap rekriteFaz 2
  • Regions Hospital, Saint Paul
  • United Hospital, Saint Paul
Laj 18 ak plis · Fanm · Mizajou Sep 28, 2026 · NCT05112601

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Ap rekriteFaz 3
  • USOR - Minnesota Oncology-Maplewood Clinic, Maplewood · 5 mi lwen
  • USOR - Minnesota Oncology/ Maplewood Clinic, Maplewood · 5 mi lwen
  • USOR - Minnesota Oncology/ Woodbury Clinic, Woodbury · 7 mi lwen
Laj 18 ak plis · Fanm · Mizajou Sep 9, 2026 · NCT07166094

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2
  • USOR Minnesota Oncology Hematology, Maplewood · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

Etid Kansè Endomèt nan lòt vil

Lòt etid nan Saint Paul

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.